Showing results (1-10 of 35) with videos related to

Sort By:
Pageof 4
NPJ Vaccines|November 24, 2017
Genetic stability of Rift Valley fever virus MP-12 vaccine during serial passages in culture cellsNandadeva Lokugamage, Tetsuro Ikegami
Journal of Virology|January 29, 2016
The L, M, and S Segments of Rift Valley Fever Virus MP-12 Vaccine Independently Contribute to a Temperature-Sensitive PhenotypeShoko Nishiyama, Nandadeva Lokugamage, Tetsuro Ikegami
Plos Neglected Tropical Diseases|November 22, 2019
Rescue of infectious Arumowot virus from cloned cDNA: Posttranslational degradation of Arumowot virus NSs protein in human cellsHoai J Hallam, Nandadeva Lokugamage, Tetsuro Ikegami
Methods in Molecular Biology (Clifton, N.J.)|April 15, 2016
Application of Droplet Digital PCR to Validate Rift Valley Fever VaccinesHoai J Ly, Nandadeva Lokugamage, Tetsuro Ikegami
Frontiers in Immunology|January 8, 2021
Experimental Nanovaccine Offers Protection Against Repeat Exposures to Trypanosoma cruzi Through Activation of Polyfunctional T Cell ResponseImran H Chowdhury, Nandadeva Lokugamage, Nisha Jain Garg
Viruses|May 28, 2016
Mutational Analysis of the Rift Valley Fever Virus Glycoprotein Precursor Proteins for Gn Protein ExpressionInaia Phoenix, Nandadeva Lokugamage, Shoko Nishiyama, et al.
Plos One|September 20, 2017
Risk analysis of inter-species reassortment through a Rift Valley fever phlebovirus MP-12 vaccine strainHoai J Ly, Nandadeva Lokugamage, Shoko Nishiyama, et al.
Journal of Virology|October 5, 2012
Genetic subpopulations of Rift Valley fever virus strains ZH548 and MP-12 and recombinant MP-12 strainsNandadeva Lokugamage, Alexander N Freiberg, John C Morrill, et al.
Pageof 4